Quantcast

Health Care Sector Update for 06/12/2018: PSTI,SURF


Shutterstock photo

Top Health Care Stocks

JNJ -0.02%

PFE +0.04%

ABT -0.21%

MRK +0.12%

AMGN -0.01%

Health care stocks were little changed Tuesday afternoon, including a less than 0.1% gain for the NYSE Health Care Index. Shares of health care companies in the S&P 500 were down less than 0.1% as a group in recent trading although the Nasdaq Biotechnology index was rising over 1.0% during the day.

Among health care stocks moving on news:

- Pluristem Therapeutics ( PSTI ) has turned solidly lower Tuesday afternoon, reversing a nearly 9% advance soon after the opening bell that followed the Israeli biotech company reporting postive top-line results from phase II testing of its PLX-PAD cells in patients with leg pain. The company said the genetic treatment reduced the incidence of revascularization and improved mobility in patients with intermittent claudication and validates the design of its upcoming phase III trial.

In other sector news:

Surface Oncology ( SURF ) declined Tuesday after the early-stage immuno-oncology company said it has begun phase I testing of its SRF373 human antibody targeting the CD73 enzyme. CD73 is critical to the production of extracellular adenosine and suppresses the ability of the immune system to recognize and attack tumors. SRF373 exhibited potent CD73 enzymatic inhibition during pre-clinical trials and reduced adenosine and increased the activity of immune cells, the company said.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.



This article appears in: Investing , US Markets
Referenced Symbols: PSTI , SURF



More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities










Research Brokers before you trade

Want to trade FX?